Cassandra Aesoph
Family · Aberdeen, SDNPI 1225698723
Payments from drug & device makers
Across 24 payments — averaging $17.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alkermes, Inc.$139
- AbbVie$113
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$36
- Biohaven Pharmaceutical Holding Company Ltd.$24
- Johnson & Johnson$20
- Pfizer$17
- plus $76 from 5 others
What the payments were for
- Food & beverage$425100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alkermes, Inc. | 6 | $139 |
| AbbVie | 7 | $113 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $36 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $24 |
| Johnson & Johnson | 1 | $20 |
| Pfizer | 1 | $17 |
| Exact Sciences | 1 | $17 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
| Lilly USA, LLC | 1 | $16 |
| Neurocrine Biosciences, Inc. | 1 | $15 |
| Organon | 2 | $13 |
How this compares
$425 in reported general payments places this provider in the 60th percentile of 588 family providers in South Dakota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 12 | $461 |
| Amlodipine Besylate | 56 | $280 |
| Cyclobenzaprine Hcl | 24 | $240 |
| Levothyroxine Sodium | 34 | $236 |
| Amitriptyline Hcl | 25 | $177 |
| Losartan Potassium | 33 | $163 |
| Potassium Chloride | 13 | $159 |
| Topiramate | 17 | $154 |
| Rosuvastatin Calcium | 31 | $152 |
| Lisinopril | 14 | $95 |
| Metoprolol Succinate | 15 | $84 |
| Famotidine | 19 | $83 |
| Atorvastatin Calcium | 15 | $77 |
| Omeprazole | 14 | $73 |
| Hydrochlorothiazide | 18 | $60 |
Paid to pharmacies, not to this prescriber.
Other family in Aberdeen
- Claire KastrupAberdeen$5K
- Sarah SiebertAberdeen$4K
- Brittany WangsnessSioux Falls$79K
- Stephanie PreisterSioux Falls$12K
- Claudia HouglandRapid City$9K
- Maria AzpeitiaDakota Dunes$8K
- Michelle VanhoveSioux Falls$7K
- Sandra EricksonHerreid$7K
- Melissa OwensRapid City$6K
- Heidi FurthSioux Falls$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.